SR-BI mediates high density lipoprotein (HDL)-induced anti-inflammatory effect in macrophages

Biochemical and Biophysical Research Communications

Volumn 457, Issue 1, 2015, Pages 112-118

  Jee Song, Gyun ^a   Kim, Seong Min ^a   Park, Ki Hoon ^a   Kim, Jihoe ^a   Choi, Inho ^a   Cho, Kyung Hyun ^a  

^a Yeungnam University   (South Korea)

Author keywords

Anti inflammation; ApoA I; Glycated HDL; HDL; Macrophages; SR BI

Indexed keywords

ABC TRANSPORTER G1; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN; SCAVENGER RECEPTOR BI; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CD36 ANTIGEN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LIGAND BINDING; MACROPHAGE; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; BIOLOGICAL MODEL; GLYCOSYLATION; METABOLISM; PATHOLOGY;

ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD36; GLYCOSYLATION; HUMANS; INFLAMMATION; LIPOPROTEINS, HDL; MACROPHAGES; MODELS, BIOLOGICAL; UP-REGULATION;

EID: 84921631403     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.12.028     Document Type: Article

References (29)

1. N.E. Miller, Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis, Am. Heart J. 113 (1987) 589-597.
2. B.H. Subedi, P.H. Joshi, S.R. Jones, et al., Current guidelines for high-density lipoprotein cholesterol in therapy and future directions, Vasc. Health Risk Manage. 10 (2014) 205-216.
3. W. Annema, A. von Eckardstein, High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis, Circ. J. 77 (2013) 2432-2448.
4. K.A. Rye, P.J. Barter, Cardioprotective functions of HDLs, J. Lipid Res. 55 (2014) 168-179.
5. A.M. Cheng, P. Handa, S. Tateya, et al., Apolipoprotein A-I attenuates palmitatemediated NF-kappaB activation by reducing Toll-like receptor-4 recruitment into lipid rafts, PLoS ONE 7 (2012) e33917.
6. S.J. Nicholls, G.J. Dusting, B. Cutri, et al., Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits, Circulation 111 (2005) 1543-1550.
7. L.K. Curtiss, J.L. Witztum, A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glycosylated low density lipoproteins, J. Clin. Invest. 72 (1983) 1427-1438.
8. R.T. Hurst, R.W. Lee, Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management, Ann. Intern. Med. 139 (2003) 824-834.
9. K.H. Park, D.G. Shin, K.H. Cho, Dysfunctional lipoproteins from young smokers exacerbate cellular senescence and atherogenesis with smaller particle size and severe oxidation and glycation, Toxicol. Sci. 140 (2014) 16-25.
10. K.H. Park, K.H. Cho, High-density lipoprotein (HDL) from elderly and reconstituted HDL containing glycated apolipoproteins A-I share proatherosclerotic and prosenescent properties with increased cholesterol influx, J. Gerontol. A Biol. Sci. Med. Sci. 66 (2011) 511-520.
11. D. Rhainds, L. Brissette, The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. Defining the rules for lipid traders, Int. J. Biochem. Cell Biol. 36 (2004) 39-77.
12. S.L. Acton, P.E. Scherer, H.F. Lodish, et al., Expression cloning of SR-BI, a CD36-related class B scavenger receptor, J. Biol. Chem. 269 (1994) 21003-21009.
13. S.W. Altmann, H.R. Davis Jr., X. Yao, et al., The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption, Biochim. Biophys. Acta 1580 (2002) 77-93.
14. N. Ohgami, R. Nagai, M. Ikemoto, et al., CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products, Ann. N. Y. Acad. Sci. 947 (2001) 350-355.
15. Y. Ji, N. Wang, R. Ramakrishnan, et al., Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile, J. Biol. Chem. 274 (1999) 33398-33402.
16. S. Acton, A. Rigotti, K.T. Landschulz, et al., Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science 271 (1996) 518-520.
17. X.A. Li, W.B. Titlow, B.A. Jackson, et al., High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner, J. Biol. Chem. 277 (2002) 11058-11063.
18. R.J. Havel, H.A. Eder, J.H. Bragdon, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest. 34 (1955) 1345-1353.
19. H.B. Brewer Jr., R. Ronan, M. Meng, et al., Isolation and characterization of apolipoproteins A-I, A-II, and A-IV, Methods Enzymol. 128 (1986) 223-246.
20. K.H. Park, J.M. Kim, K.H. Cho, Elaidic acid (EA) generates dysfunctional highdensity lipoproteins and consumption of EA exacerbates hyperlipidemia and fatty liver change in zebrafish, Mol. Nutr. Food Res. 58 (2014) 1537-1545.
21. K.H. Park, W. Jang, K.Y. Kim, et al., Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipidbound state with acceleration of atherosclerosis and senescence, Biochem. Biophys. Res. Commun. 392 (2010) 295-300.
22. C. Gasparini, M. Feldmann, NF-kappaB as a target for modulating inflammatory responses, Curr. Pharm. Des. 18 (2012) 5735-5745.
23. E. Nobecourt, F. Tabet, G. Lambert, et al., Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I, Arterioscler. Thromb. Vasc. Biol. 30 (2010) 766-772.
24. E.P. van der Vorst, L.Z. Vanags, L.L. Dunn, et al., High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells, FASEB J. 27 (2013) 1413-1425.
25. A. Rigotti, E.R. Edelman, P. Seifert, et al., Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland, J. Biol. Chem. 271 (1996) 33545-33549.
26. A.L. Tondu, C. Robichon, L. Yvan-Charvet, et al., Insulin and angiotensin II induce the translocation of scavenger receptor class B, type I from intracellular sites to the plasma membrane of adipocytes, J. Biol. Chem. 280 (2005) 33536-33540.
27. Y. Ji, B. Jian, N. Wang, et al., Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux, J. Biol. Chem. 272 (1997) 20982-20985.
28. N. Ohgami, A. Miyazaki, M. Sakai, et al., Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to cholesterol metabolism, J. Atheroscler. Thromb. 10 (2003) 1-6.
29. C. Ott, K. Jacobs, E. Haucke, et al., Role of advanced glycation end products in cellular signaling, Redox Biol. 2 (2014) 411-429.